HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
2276studies shown
Showing 1,633-1,644 of 2,276
Behavioral study icon
CompletedACTRN12617000457347

LifeSpan: A whole-population stepped-wedge cluster-study of a multilevel systems approach to reduce Suicide prevention and deaths in four NSW regions.

Official study title

LifeSpan: A stepped-wedge cluster-randomized trial of a multi-level systems approach to suicide prevention, including means restrictions, community based campaigns and enhanced identification and treatment of suicidal individuals to reduce suicide attempts and deaths in individuals of all ages in four sites in New South Wales.

This study has finished and is no longer accepting participants.

In Australia
SuicidalityInterventional study
Countries
Australia
Sponsor
Black Dog Institute/UNSW
Behavioral study icon
CompletedACTRN12625000049471

Lights Out Online: Examining the Efficacy of Therapist Assistance via Videoconference in Parents of Young Children with Behavioural Sleep Problems

Official study title

Examining the Efficacy of a therapist assisted videoconferencing adjunct to the Lights Out Online CBT program in improving child behavioural sleep problems and parent mental health

This study has finished and is no longer accepting participants.

Remote / online
Anxiety, DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
Griffith University
Drug study icon
CompletedACTRN12617000657325

Lisdexamfetamine for methamphetamine addiction

Official study title

A randomised double blind placebo controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

This study has finished and is no longer accepting participants.

In Australia
AddictionInterventional studyAges 18–65
Countries
Australia
Sponsor
University of New South Wales
Drug study icon
CompletedNCT02672111

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Addiction

What is this study about?

Researchers compared CAM2038 q1w or q4w exposure to SL BPN/NX and CAM2038 q1w or q4w new to BPN treatment, tracking side effects to assess long-term safety in adults with opioid dependence.

This study has finished and is no longer accepting participants.

In Australia
AddictionMedication studyAges 18–65
Countries
Australia, United States, United Kingdom, + 5 others
Sponsor
Braeburn Pharmaceuticals
Drug study icon
CompletedNCT00190684

Long-Term, Open Label Atomoxetine Study

What is this study about?

Researchers studied atomoxetine, tracking side effects to assess long-term safety in people with ADHD.

This study has finished and is no longer accepting participants.

In Australia
ADHDMedication studyAges 6–18
Countries
Australia, United States, France, + 10 others
Sponsor
Eli Lilly and Company
Drug study icon
TerminatedACTRN12615000376549

Low Dose Atomoxetine in Cardiovascular Disease: A Study

Official study title

Effect of low dose Atomoxetine on stress/anxiety levels and cardiovascular risk in patients with hypertension, hypercholesterolemia, diabetes or other cardiovascular disease.

This study ended early.

In Australia
AnxietyInterventional studyAges 18–80
Countries
Australia
Sponsor
Professor Simon Dimmitt
Device study icon
CompletedACTRN12624000600549

Low-Intensity Transcranial Focused Ultrasound for OCD

Official study title

Modulation of Brain Network Activity in Obsessive-Compulsive Disorder Using Low-Intensity Transcranial Focused Ultrasound

This study has finished and is no longer accepting participants.

In Australia
OCDInterventional studyAges 18–50
Countries
Australia
Sponsor
QIMR Berghofer Medical Research Institute

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.